COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,556 Articles (22,881 medRxiv, 8,675 bioRxiv)

Most recent first Previous |  Page 686: Articles 6851-6860  | Next

T cell responses to SARS-CoV-2 vaccination in people with multiple sclerosis differ between disease-modifying therapies
Wolf, A.-S., Ravussin, A., König, M., Overas, M. H., Solum, G., Kjonstad, I. F., Chopra, A., Holmoy, T., Harbo, H. F., Syversen, S. W., Jorgensen, K. K., Hogestol, E., Vaage, J. T., Celius, E. G., Lund-Johansen, F., Munthe, L. A., Nygaard, G. O., Mjaaland, S.
10.1101/2022.08.25.22279202 — Posted: 2022-08-25
Nirmatrelvir/ritonavir and molnuipiravir in the treatment of mild/moderate COVID-19: results of a real-life study
Gentile, I., Scotto, R., Schiano Moriello, N., Pinchera, B., Villari, R., Trucillo, E., Ametrano, L., Fusco, L., Castaldo, G., Buonomo, A. R., Federico II COVID Team
10.1101/2022.08.23.22278585 — Posted: 2022-08-25
Correlation of patient serum IgG, IgA and IgM antigen binding with COVID-19 disease severity using multiplexed SARS-CoV-2 antigen microarray and maintained relative IgA and IgM antigen binding over time
Le Berre, M., Paulovcakova, T., De Marco Verissimo, C., Doyle, S., Dalton, J. P., Masterson, C., Ribes Martinez, E., Walsh, L., Gormley, C., Laffey, J. G., McNicholas, B., Simpkin, A. J., Kilcoyne, M.
10.1101/2022.08.22.22278930 — Posted: 2022-08-25
Variability in mRNA SARS-CoV-2 BNT162b2 vaccine immunogenicity is associated with differences in the gut microbiome and habitual dietary fibre intake
Healey, G. R., Golding, L., Schick, A., Majdoubi, A., Lavoie, P., Vallance, B.
10.1101/2022.08.24.22279143 — Posted: 2022-08-25
TRENDS IN CASES, HOSPITALISATION AND MORTALITY RELATED TO THE OMICRON BA.4/BA.5 SUB-VARIANTS IN SOUTH AFRICA
JASSAT, W., Abdool Karim, S., Ozougwu, L., Welch, R., Mudara, C., Masha, M., Rousseau, P., Wolmarans, M., Selikow, A., Govender, N., Walaza, S., von Gottberg, A., Wolter, N., Pisa, P. T., Sanne, I., Govender, S., Blumberg, L., Cohen, C., Groome, M.
10.1101/2022.08.24.22279197 — Posted: 2022-08-25
Dynamics of anti-S IgG antibodies titers after the second dose of COVID 19 mRNA and non-mRNA vaccines in the manual and craft worker population of Qatar
Bansal, D., Atia, H., Al Badr, M., Nour, M., Abdulmajeed, J., Hasan, A., Al-Hajri, N., Ahmed, L., Ibrahim, R., Zamel, R., Mohamed, A., Pattalaparambil, H., Daraan, F., Chaudhry, A., Oraby, S., El-Saleh, S., El-Shafie, S. S., Al-Farsi, A. F., Paul, J., Ismail, A., Al-Romaihi, H. E., Al-Thani, M. H., Doi, S. A. R., Zughaier, S. M., Cyprian, F., Farag, E., Farooqui, H. H.
10.1101/2022.08.24.22279159 — Posted: 2022-08-25
The Role of Modelling and Analytics in South African COVID-19 Planning and Budgeting
Meyer-Rath, G., Hounsell, R., Pulliam, J., Jamieson, L., Nichols, B., Moultrie, H., Silal, S. P.
10.1101/2022.08.23.22279123 — Posted: 2022-08-25
Hospital bed capacity across in Tunisia hospital during the first four waves of the COVID-19 pandemic: A descriptive analysis
ben miled, s., Borgi, c., Hsairi, m., Somrani, N., kebir, a.
10.1101/2022.08.23.22279122 — Posted: 2022-08-25
ENHANCED RECOMBINATION AMONG SARS-COV-2 OMICRON VARIANTS CONTRIBUTES TO VIRAL IMMUNE ESCAPE.
Shiraz, R., Tripathi, S.
10.1101/2022.08.23.504936 — Posted: 2022-08-24
Human anti-ACE2 monoclonal antibodies as pan-sarbecovirus prophylactic agents
Zhang, F., Jenkins, J., de Carvalho, R. V. H., Nakandakari-Higa, S., Chen, T., Abernathy, M. E., Nyakatura, E., Andrew, D., Lebedeva, I. V., Lorenz, I. C., Hoffmann, H.- H., Rice, C. M., Victora, G. D., Barnes, C. O., Hatziioannou, T., Bieniasz, P. D.
10.1101/2022.08.24.505169 — Posted: 2022-08-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).